RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 1.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,066,345 | +31.3% | 177,376 | -5.5% | 0.00% | 0.0% |
Q2 2023 | $3,096,756 | +549.5% | 187,796 | +602.7% | 0.00% | – |
Q1 2023 | $476,791 | -49.3% | 26,726 | -17.2% | 0.00% | – |
Q4 2022 | $940,081 | -3.9% | 32,283 | -19.1% | 0.00% | – |
Q3 2022 | $978,000 | +998.9% | 39,908 | +85.7% | 0.00% | – |
Q2 2022 | $89,000 | -94.9% | 21,495 | -85.9% | 0.00% | – |
Q1 2022 | $1,756,000 | +12.1% | 152,349 | -2.9% | 0.00% | – |
Q4 2021 | $1,566,000 | -23.3% | 156,918 | +0.3% | 0.00% | – |
Q3 2021 | $2,043,000 | -25.5% | 156,423 | +11.7% | 0.00% | -100.0% |
Q2 2021 | $2,741,000 | -5.4% | 140,032 | +2.8% | 0.00% | 0.0% |
Q1 2021 | $2,896,000 | -25.3% | 136,154 | +4.4% | 0.00% | 0.0% |
Q4 2020 | $3,878,000 | +43.5% | 130,422 | +4.6% | 0.00% | 0.0% |
Q3 2020 | $2,702,000 | -4.1% | 124,688 | -1.3% | 0.00% | 0.0% |
Q2 2020 | $2,817,000 | +59.8% | 126,306 | +9.0% | 0.00% | 0.0% |
Q1 2020 | $1,763,000 | -30.2% | 115,830 | +5.4% | 0.00% | 0.0% |
Q4 2019 | $2,524,000 | +36.9% | 109,940 | +28.7% | 0.00% | 0.0% |
Q3 2019 | $1,844,000 | -2.6% | 85,430 | -0.7% | 0.00% | 0.0% |
Q2 2019 | $1,894,000 | -0.6% | 86,059 | +23.7% | 0.00% | 0.0% |
Q1 2019 | $1,906,000 | +5.7% | 69,552 | +3.7% | 0.00% | 0.0% |
Q4 2018 | $1,804,000 | +2.6% | 67,088 | +11.3% | 0.00% | – |
Q3 2018 | $1,759,000 | +48.9% | 60,274 | +59.5% | 0.00% | – |
Q2 2018 | $1,181,000 | +143.5% | 37,793 | +55.3% | 0.00% | – |
Q1 2018 | $485,000 | -7.3% | 24,331 | +35.1% | 0.00% | – |
Q4 2017 | $523,000 | – | 18,008 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEA Management Company, LLC | 4,909,956 | $142,977,919 | 8.04% |
Opaleye Management Inc. | 735,000 | $21,403,200 | 7.44% |
Frazier Life Sciences Management, L.P. | 1,894,000 | $55,153,280 | 3.43% |
RA Capital Management | 5,516,067 | $160,627,871 | 3.26% |
Altium Capital Management LP | 170,000 | $4,950,400 | 2.52% |
Samsara BioCapital, LLC | 345,293 | $10,054,932 | 2.16% |
Rock Springs Capital Management LP | 1,760,865 | $51,276,389 | 1.23% |
Parkman Healthcare Partners LLC | 157,862 | $4,596,941 | 1.22% |
Baker Brothers Advisors | 6,354,608 | $185,046,185 | 1.11% |
EAM Investors, LLC | 164,695 | $4,795,918 | 0.99% |